Visufarma Uk

Visufarma Uk company information, Employees & Contact Information

Explore related pages

Related company profiles:

VISUfarma is a pan-European ophthalmic pharmaceutical company with a clear mission: To bring quality products and global therapeutic innovation to European eye health. We are an ambitious and fast growing ophthalmology company, commercialising a broad portfolio of pharmaceutical products and medical devices across Europe. The company was formed in 2016 and is the result of the successful combination of the Italian company Visufarma SpA and the commercial activities of the international Nicox SA, headquartered in France. The combination created VISUfarma. We offer a complete portfolio of products in the areas of: Dry Eye, eyelid hygiene, Meibomian Gland Dysfunction (MGD), Blepharitis & Demodex management, retinal health, food supplements and Glaucoma. VISUfarma UK manages a unique network in the ophthalmology world which enables doctors, hospitals and clinics to provide patients with the best eye care. VISUfarma UK also manages a unique network in the optometry world which enables the optometrists in the optician practices to provide patients with the best eye care on the UK high street. Our growing portfolio of innovative products, and our commitment to ocular health, will bring new therapeutic solutions from around the world to help patients across Europe and in 20+ countries worldwide through exclusive distributors. VISUfarma UK HQ are based in Leeds, West Yorkshire.

Company Details

Employees
14
Address
4230 Park Approach, Leeds,england Ls15 8gb,united Kingdom
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Leeds, England
Looking for a particular Visufarma Uk employee's phone or email?

Visufarma Uk Questions

News

GHO Capital Sells VISUfarma to Lupin - Yahoo! Finance UK

GHO Capital Sells VISUfarma to Lupin Yahoo! Finance UK

GHO Capital Sells VISUfarma to Lupin - GlobeNewswire

GHO Capital Sells VISUfarma to Lupin GlobeNewswire

Lupin Expands In Europe With €190m VISUfarma Acquisition - Citeline News & Insights

Lupin Expands In Europe With €190m VISUfarma Acquisition Citeline News & Insights

Lupin sharpens Ophthalmic focus with ₹2000 cr VISUfarma buyout - ETPharma.com

Lupin sharpens Ophthalmic focus with ₹2000 cr VISUfarma buyout ETPharma.com

Lupin Shares Trading Flat as Unit Acquires VISUfarma for Rs 1,970 Crore - Equitypandit

Lupin Shares Trading Flat as Unit Acquires VISUfarma for Rs 1,970 Crore Equitypandit

Lupin acquires VISUfarma from GHO Capital - Drug Store News

Lupin acquires VISUfarma from GHO Capital Drug Store News

Lupin Acquires VISUfarma To Expand European Ophthalmology Market Presence - NDTV Profit

Lupin Acquires VISUfarma To Expand European Ophthalmology Market Presence NDTV Profit

Lupin subsidiary Nanomi BV inks pact to acquire Netherlands-based VISUfarma - Business Standard

Lupin subsidiary Nanomi BV inks pact to acquire Netherlands-based VISUfarma Business Standard

Lupin to Acquire Dutch Eye-Care Firm VISUfarma for Euro 190 Million - Deccan Chronicle

Lupin to Acquire Dutch Eye-Care Firm VISUfarma for Euro 190 Million Deccan Chronicle

Lupin to acquire VISUfarma for euro 190 million, expanding European specialty footprint - Moneycontrol

Lupin to acquire VISUfarma for euro 190 million, expanding European specialty footprint Moneycontrol

Lupin shares in focus as arm buys VISUfarma for Rs 1,970 crore - Business Today

Lupin shares in focus as arm buys VISUfarma for Rs 1,970 crore Business Today

Lupin acquires VISUfarma to strengthen specialty ophthalmology portfolio - IndiaMedToday

Lupin acquires VISUfarma to strengthen specialty ophthalmology portfolio IndiaMedToday

Lupin to acquire VISUfarma BV for €190 mn to expand European eyecare reach - Business Standard

Lupin to acquire VISUfarma BV for €190 mn to expand European eyecare reach Business Standard

Lupin subsidiary Nanomi B.V. to acquire VISUfarma B.V. for €190 million - Business Upturn

Lupin subsidiary Nanomi B.V. to acquire VISUfarma B.V. for €190 million Business Upturn

Top Visufarma Uk Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant